.Merck beats incomes expectations, increases sales overview on sturdy demand for top medications like Keytruda CNBCMerck & Co. (MRK US) Beats Profit Estimates as Keytruda Purchases Rise BloombergMerck Supply: Pharma Titan Posts Solid End Results, However Outlook Drops Short Capitalist's Company DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats revenue and sales desires amid Keytruda strong point, however provides blended full-year expectation MarketWatch.